Oxford Vaccine Safe, Even The Elderly Responding: Serum Institute Chief | Read

  • 4:02
  • Published On: October 28, 2020
Cinema View
Embed
The Oxford University's Covishield vaccine for coronavirus has drawn an immune response even in the elderly, who are among the groups vulnerable to the disease, Adar Poonawala, the chief of Serum Institute of Imdia, which is partnering the UK-based premier university, told NDTV today. The vaccine, he said, is "very safe". "Thousands of people have had it in India and abroad so we are cracking on track with no safety concerns," he added.

Related Videos

AstraZeneca Initiates A Global Withdrawal Of Its Covid-19 Vaccine
May 08, 2024 2:12
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
May 08, 2024 2:54
AstraZeneca Withdraws Covid Vaccine, Cites Commercial Reasons: Report
May 08, 2024 0:45
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
May 06, 2024 1:53
"Doctors Were Clueless, Didn't Suspect Vaccine": Man Whose Daughter Died Due To Vaccine Side-Effect
May 05, 2024 4:27
"Information Is Not New, No Need To Worry": Ex WHO Chief Scientist On Covishield Concern
May 05, 2024 4:56
"All Drugs, Vaccines Come With Some Side-Effects": Top Expert
May 05, 2024 1:07
"No Vaccine Is 100% Effective Or 100% Safe": Expert On Covishield Concern
May 05, 2024 2:18
Ex WHO Chief Scientist, Top Doctors Answer AstraZeneca Vaccine Concerns
May 05, 2024 26:44
AstraZeneca Covid 19 Vaccine Side Effects | What Is TTS, A Rare Condition Caused By Covishield
May 01, 2024 4:03
Covishield Vaccine से हो सकता है Heart Attack! AstraZeneca ने कबूली बात
May 01, 2024 3:36
Astrazeneca's Big U-Turn, Admits Rare Blood Clot Risk
April 30, 2024 2:21
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination